Shixue Chen

762 total citations
27 papers, 567 citations indexed

About

Shixue Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Shixue Chen has authored 27 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Shixue Chen's work include Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Shixue Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Shixue Chen collaborates with scholars based in China, Japan and United States. Shixue Chen's co-authors include Xudong Chen, Jikai Zhou, Yi Hu, Junxun Ma, Zhaozhen Wu, Jinliang Wang, Pengfei Cui, Haitao Tao, Yuanyong Yao and Di Huang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Biological Macromolecules.

In The Last Decade

Shixue Chen

26 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shixue Chen China 14 316 139 101 92 88 27 567
Paolo Oliva Italy 8 93 0.3× 26 0.2× 23 0.2× 46 0.5× 26 0.3× 11 409
Feng Shen China 12 87 0.3× 51 0.4× 12 0.1× 19 0.2× 88 1.0× 40 643
Lin Dang China 14 289 0.9× 144 1.0× 8 0.1× 172 1.9× 46 0.5× 34 786
Jinjun Ye China 16 171 0.5× 279 2.0× 3 0.0× 38 0.4× 138 1.6× 53 662
Fuxi Li China 15 70 0.2× 31 0.2× 21 0.2× 14 0.2× 43 0.5× 23 702
Mengmeng Jiang China 10 122 0.4× 18 0.1× 46 0.5× 139 1.5× 26 0.3× 27 400
Chenyang Xu China 13 101 0.3× 79 0.6× 5 0.0× 79 0.9× 41 0.5× 45 662
Mengke Fan China 12 167 0.5× 141 1.0× 3 0.0× 56 0.6× 189 2.1× 48 613
Chunshui Liu China 11 64 0.2× 26 0.2× 30 0.3× 15 0.2× 17 0.2× 19 320
Yongbiao Huang China 13 127 0.4× 106 0.8× 17 0.2× 54 0.6× 25 0.3× 41 448

Countries citing papers authored by Shixue Chen

Since Specialization
Citations

This map shows the geographic impact of Shixue Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shixue Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shixue Chen more than expected).

Fields of papers citing papers by Shixue Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shixue Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shixue Chen. The network helps show where Shixue Chen may publish in the future.

Co-authorship network of co-authors of Shixue Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shixue Chen. A scholar is included among the top collaborators of Shixue Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shixue Chen. Shixue Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yao, Yuanyong, Qi Huang, Jia‐Rong Chen, et al.. (2024). The novel mechanism on the inhibition of superoxide anion generating from xanthine oxidase in the presence of myricetin. International Journal of Biological Macromolecules. 283(Pt 1). 137636–137636. 2 indexed citations
3.
4.
Yao, Yuanyong, Shixue Chen, & Meng Zhang. (2022). Sustainable Approaches to Selective Conversion of Cellulose Into 5-Hydroxymethylfurfural Promoted by Heterogeneous Acid Catalysts: A Review. Frontiers in Chemistry. 10. 880603–880603. 22 indexed citations
5.
Wang, Peng, Tingting Liu, Shixue Chen, et al.. (2021). Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101748–101748. 8 indexed citations
6.
Wu, Zhaozhen, Haitao Tao, Sujie Zhang, et al.. (2021). Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting. Cancer Immunology Immunotherapy. 70(10). 2971–2980. 10 indexed citations
7.
Chen, Shixue, Zhibo Zhang, Xuan Zheng, et al.. (2021). Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 562315–562315. 83 indexed citations
8.
Chen, Shixue, Ruixin Li, Zhibo Zhang, et al.. (2021). Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors. Translational Lung Cancer Research. 10(3). 1397–1407. 20 indexed citations
9.
Wu, Zhaozhen, Pengfei Cui, Haitao Tao, et al.. (2021). The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors. Clinical Medicine Insights Oncology. 15. 43 indexed citations
10.
Huang, Ziwei, Qi Xiong, Haitao Tao, et al.. (2021). Efficacy and safety of crizotinib plus bevacizumab in ALK/ROS-1/c-MET positive non-small cell lung cancer: an open-label, single-arm, prospective observational study.. PubMed. 13(3). 1526–1534. 11 indexed citations
11.
Yao, Yuanyong, Shixue Chen, & Hu Li. (2021). An Improved System to Evaluate Superoxide‐Scavenging Effects of Bioflavonoids. ChemistryOpen. 10(4). 503–514. 15 indexed citations
12.
Chen, Shixue, Ziwei Huang, Wangping Jia, et al.. (2020). <p>Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors</p>. Journal of Hepatocellular Carcinoma. Volume 7. 289–299. 24 indexed citations
13.
Yao, Yuanyong, et al.. (2020). Evaluation of General Synthesis Procedures for Bioflavonoid–Metal Complexes in Air-Saturated Alkaline Solutions. Frontiers in Chemistry. 8. 589–589. 7 indexed citations
14.
Cui, Pengfei, Di Huang, Zhaozhen Wu, et al.. (2020). Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 12. 3863537073–3863537073. 28 indexed citations
15.
Ma, Junxun, Danyang Sun, Jinliang Wang, et al.. (2020). Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients. Cancer Immunology Immunotherapy. 69(3). 365–372. 23 indexed citations
16.
Huang, Di, Fan Zhang, Haitao Tao, et al.. (2020). Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer. Targeted Oncology. 15(1). 93–100. 25 indexed citations
17.
Sun, Danyang, Junxun Ma, Jinliang Wang, et al.. (2019). Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer. Cancer Immunology Immunotherapy. 68(9). 1527–1535. 39 indexed citations
18.
Chen, Shixue, Lingling Li, Fan Zhang, et al.. (2019). Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy. Journal of Immunology Research. 2019. 1–13. 10 indexed citations
19.
Chen, Yi, Jinyu Li, Shixue Chen, et al.. (2017). Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer. Scientific Reports. 7(1). 10760–10760. 18 indexed citations
20.
Yao, Yuanyong, et al.. (2017). Utilization of Solid Acid SO42−/TiO2 as Catalyst to the Three‐Component Mannich Reaction at Ambient Temperature. Journal of Heterocyclic Chemistry. 54(4). 2520–2528. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Oliva Breakdown of academic impact, for papers by Feng Shen Breakdown of academic impact, for papers by Lin Dang Breakdown of academic impact, for papers by Jinjun Ye Breakdown of academic impact, for papers by Fuxi Li Breakdown of academic impact, for papers by Mengmeng Jiang Breakdown of academic impact, for papers by Chenyang Xu Breakdown of academic impact, for papers by Mengke Fan Breakdown of academic impact, for papers by Chunshui Liu Breakdown of academic impact, for papers by Yongbiao Huang
Rankless by CCL
2026